Northern Technologies International (NTIC) Reaches New 12-Month Low at $24.02

Quantum Capital Management grew its holdings in Northern Technologies International by 10.5% during the 4th quarter. Quantum Capital …

Northern Technologies International logoNorthern Technologies International Co. (NASDAQ:NTIC)’s share price hit a new 52-week low during trading on Tuesday . The stock traded as low as $24.02 and last traded at $24.02, with a volume of 554 shares traded. The stock had previously closed at $24.55.

Separately, ValuEngine raised shares of Northern Technologies International from a “sell” rating to a “hold” rating in a research report on Wednesday, January 2nd.

The stock has a market capitalization of $113.50 million, a P/E ratio of 17.48 and a beta of 1.08.

Northern Technologies International (NASDAQ:NTIC) last issued its quarterly earnings results on Friday, April 5th. The specialty chemicals company reported $0.30 EPS for the quarter. Northern Technologies International had a net margin of 13.04% and a return on equity of 12.70%. The firm had revenue of $13.32 million during the quarter. On average, research analysts predict that Northern Technologies International Co. will post 1.75 EPS for the current year.

Institutional investors have recently added to or reduced their stakes in the company. Bank of America Corp DE acquired a new stake in shares of Northern Technologies International in the fourth quarter worth $204,000. FMR LLC increased its position in shares of Northern Technologies International by 19.9% in the third quarter. FMR LLC now owns 36,704 shares of the specialty chemicals company’s stock worth $1,274,000 after acquiring an additional 6,098 shares in the last quarter. Quantum Capital Management grew its holdings in Northern Technologies International by 10.5% during the 4th quarter. Quantum Capital Management now owns 49,737 shares of the specialty chemicals company’s stock valued at $1,472,000 after purchasing an additional 4,722 shares in the last quarter. Renaissance Technologies LLC grew its holdings in Northern Technologies International by 43.6% during the 3rd quarter. Renaissance Technologies LLC now owns 59,900 shares of the specialty chemicals company’s stock valued at $2,079,000 after purchasing an additional 18,200 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Northern Technologies International by 1.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 172,473 shares of the specialty chemicals company’s stock valued at $5,103,000 after purchasing an additional 1,773 shares in the last quarter. 30.24% of the stock is owned by institutional investors.

WARNING: “Northern Technologies International (NTIC) Reaches New 12-Month Low at $24.02” was first posted by Fairfield Current and is owned by of Fairfield Current. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.fairfieldcurrent.com/news/2019/04/16/northern-technologies-international-ntic-reaches-new-12-month-low-at-24-02.html.

Northern Technologies International Company Profile (NASDAQ:NTIC)

Northern Technologies International Corporation develops and markets rust and corrosion inhibiting products and services to automotive, electronics, electrical, mechanical, military, retail consumer, and oil and gas markets. It offers rust and corrosion inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand.

Recommended Story: Why is the LIBOR significant?

Receive News & Ratings for Northern Technologies International Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Northern Technologies International and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Quaker Chemical (KWR) Lifted to Hold at Zacks Investment Research

WINTON GROUP Ltd boosted its stake in Quaker Chemical by 1,252.2% in the fourth quarter. WINTON GROUP Ltd now owns 61,933 shares of the …

Quaker Chemical logoQuaker Chemical (NYSE:KWR) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday, Zacks.com reports.

According to Zacks, “Quaker Chemical Corporation develops, produces and markets a range of formulated chemical specialty products for various heavy industrial and manufacturing applications and, in addition, offers and markets chemical management services (CMS). The Company operates in three segments: Metalworking process chemicals, Coatings and Other chemical products. The Metalworking process chemicals segment includes industrial process fluids for various heavy industrial and manufacturing applications. Coatings segment includes temporary and permanent coatings for metal and concrete products and chemical milling maskants. “

Other research analysts have also issued research reports about the stock. Janney Montgomery Scott reissued a “neutral” rating and issued a $198.00 price target on shares of Quaker Chemical in a research report on Tuesday, January 29th. Seaport Global Securities reaffirmed a “neutral” rating on shares of Quaker Chemical in a report on Tuesday, February 5th. Five equities research analysts have rated the stock with a hold rating, The company currently has an average rating of “Hold” and a consensus price target of $187.25.

Quaker Chemical stock opened at $205.83 on Wednesday. The company has a quick ratio of 2.14, a current ratio of 2.76 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $2.75 billion, a price-to-earnings ratio of 34.08, a PEG ratio of 2.67 and a beta of 1.39. Quaker Chemical has a 12 month low of $137.95 and a 12 month high of $217.15.

Quaker Chemical (NYSE:KWR) last announced its quarterly earnings data on Thursday, February 28th. The specialty chemicals company reported $1.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.40 by $0.11. The company had revenue of $211.48 million for the quarter, compared to analyst estimates of $215.90 million. Quaker Chemical had a return on equity of 18.88% and a net margin of 6.86%. As a group, analysts expect that Quaker Chemical will post 7.01 earnings per share for the current fiscal year.

In related news, insider Shane Hostetter sold 1,892 shares of the firm’s stock in a transaction on Friday, February 1st. The stock was sold at an average price of $207.51, for a total transaction of $392,608.92. Following the completion of the sale, the insider now directly owns 1,303 shares of the company’s stock, valued at approximately $270,385.53. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.90% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently modified their holdings of the business. Norges Bank bought a new position in Quaker Chemical in the fourth quarter valued at about $25,248,000. BlackRock Inc. boosted its stake in Quaker Chemical by 4.9% in the third quarter. BlackRock Inc. now owns 1,897,934 shares of the specialty chemicals company’s stock valued at $383,781,000 after acquiring an additional 87,878 shares during the last quarter. Macquarie Group Ltd. boosted its stake in Quaker Chemical by 23.4% in the third quarter. Macquarie Group Ltd. now owns 340,203 shares of the specialty chemicals company’s stock valued at $68,792,000 after acquiring an additional 64,472 shares during the last quarter. WINTON GROUP Ltd boosted its stake in Quaker Chemical by 1,252.2% in the fourth quarter. WINTON GROUP Ltd now owns 61,933 shares of the specialty chemicals company’s stock valued at $11,006,000 after acquiring an additional 57,353 shares during the last quarter. Finally, Vanguard Group Inc grew its holdings in Quaker Chemical by 1.7% during the 3rd quarter. Vanguard Group Inc now owns 1,428,100 shares of the specialty chemicals company’s stock worth $288,776,000 after acquiring an additional 23,996 shares during the period. Hedge funds and other institutional investors own 97.84% of the company’s stock.

Quaker Chemical Company Profile

Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications in North America, Europe, the Middle East, Africa, the Asia/Pacific, and South America. The company’s products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and aluminum in the hot rolling of aluminum; machining and grinding compounds for use in cutting, shaping, and grinding metal parts; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; corrosion preventives to protect metals during manufacture, storage, and shipment; and specialty greases used in automotive and aerospace production processes, steel manufacturing, and various other applications.

Featured Article: What are the economic characteristics of a bear market?

Get a free copy of the Zacks research report on Quaker Chemical (KWR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Quaker Chemical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Quaker Chemical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Bank of New York Mellon Corp Sells 6112 Shares of Quaker Chemical Corp (NYSE:KWR)

WINTON GROUP Ltd grew its stake in shares of Quaker Chemical by 1,252.2% during the fourth quarter. WINTON GROUP Ltd now owns 61,933 …

Quaker Chemical logoBank of New York Mellon Corp cut its stake in Quaker Chemical Corp (NYSE:KWR) by 3.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 166,396 shares of the specialty chemicals company’s stock after selling 6,112 shares during the period. Bank of New York Mellon Corp owned about 1.25% of Quaker Chemical worth $29,570,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of KWR. BlackRock Inc. boosted its holdings in Quaker Chemical by 4.9% in the third quarter. BlackRock Inc. now owns 1,897,934 shares of the specialty chemicals company’s stock valued at $383,781,000 after acquiring an additional 87,878 shares during the last quarter. Macquarie Group Ltd. lifted its holdings in Quaker Chemical by 23.4% in the third quarter. Macquarie Group Ltd. now owns 340,203 shares of the specialty chemicals company’s stock valued at $68,792,000 after buying an additional 64,472 shares during the period. WINTON GROUP Ltd grew its stake in shares of Quaker Chemical by 1,252.2% during the fourth quarter. WINTON GROUP Ltd now owns 61,933 shares of the specialty chemicals company’s stock worth $11,006,000 after purchasing an additional 57,353 shares during the period. Vanguard Group Inc increased its holdings in Quaker Chemical by 1.7% in the third quarter. Vanguard Group Inc now owns 1,428,100 shares of the specialty chemicals company’s stock valued at $288,776,000 after purchasing an additional 23,996 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in Quaker Chemical by 1.7% in the third quarter. Vanguard Group Inc. now owns 1,428,100 shares of the specialty chemicals company’s stock valued at $288,776,000 after buying an additional 23,996 shares during the period. Institutional investors and hedge funds own 97.84% of the company’s stock.

A number of analysts have recently commented on KWR shares. Zacks Investment Research raised Quaker Chemical from a “sell” rating to a “hold” rating in a research note on Wednesday, March 6th. Seaport Global Securities reiterated a “neutral” rating on shares of Quaker Chemical in a research report on Tuesday, February 5th. Finally, Janney Montgomery Scott restated a “neutral” rating and set a $198.00 price objective on shares of Quaker Chemical in a report on Tuesday, January 29th. Five investment analysts have rated the stock with a hold rating, The company presently has a consensus rating of “Hold” and a consensus target price of $187.25.

Shares of KWR stock traded down $3.69 during trading on Tuesday, reaching $205.83. The company’s stock had a trading volume of 52,200 shares, compared to its average volume of 73,709. The company has a quick ratio of 2.14, a current ratio of 2.76 and a debt-to-equity ratio of 0.08. Quaker Chemical Corp has a one year low of $137.95 and a one year high of $217.15. The firm has a market cap of $2.75 billion, a PE ratio of 34.08, a P/E/G ratio of 2.67 and a beta of 1.39.

Quaker Chemical (NYSE:KWR) last posted its quarterly earnings results on Thursday, February 28th. The specialty chemicals company reported $1.51 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.40 by $0.11. The firm had revenue of $211.48 million during the quarter, compared to the consensus estimate of $215.90 million. Quaker Chemical had a return on equity of 18.88% and a net margin of 6.86%. On average, equities analysts predict that Quaker Chemical Corp will post 7.01 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Tuesday, April 16th will be given a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a yield of 0.72%. The ex-dividend date of this dividend is Monday, April 15th. Quaker Chemical’s dividend payout ratio (DPR) is currently 24.50%.

In other news, insider Shane Hostetter sold 1,892 shares of Quaker Chemical stock in a transaction dated Friday, February 1st. The shares were sold at an average price of $207.51, for a total value of $392,608.92. Following the completion of the transaction, the insider now owns 1,303 shares of the company’s stock, valued at approximately $270,385.53. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 2.90% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This article was first posted by Modern Readers and is owned by of Modern Readers. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.modernreaders.com/news/2019/04/10/bank-of-new-york-mellon-corp-cuts-position-in-quaker-chemical-corp-kwr.html.

Quaker Chemical Profile

Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications in North America, Europe, the Middle East, Africa, the Asia/Pacific, and South America. Its products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and aluminum in the hot rolling of aluminum; machining and grinding compounds for use in cutting, shaping, and grinding metal parts; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; corrosion preventives to protect metals during manufacture, storage, and shipment; and specialty greases used in automotive and aerospace production processes, steel manufacturing, and various other applications.

Read More: Why is the LIBOR significant?

Institutional Ownership by Quarter for Quaker Chemical (NYSE:KWR)

Receive News & Ratings for Quaker Chemical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Quaker Chemical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Westlake Chemical Co. (WLK) Expected to Announce Quarterly Sales of $2.08 Billion

AQR Capital Management LLC boosted its stake in Westlake Chemical by 20.0% during the third quarter. AQR Capital Management LLC now owns …

Westlake Chemical logoWall Street brokerages expect that Westlake Chemical Co. (NYSE:WLK) will report sales of $2.08 billion for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Westlake Chemical’s earnings, with the lowest sales estimate coming in at $2.06 billion and the highest estimate coming in at $2.10 billion. Westlake Chemical reported sales of $2.15 billion in the same quarter last year, which indicates a negative year over year growth rate of 3.3%. The firm is expected to announce its next quarterly earnings results on Thursday, May 2nd.

On average, analysts expect that Westlake Chemical will report full year sales of $8.80 billion for the current year, with estimates ranging from $8.70 billion to $8.91 billion. For the next fiscal year, analysts anticipate that the firm will post sales of $9.53 billion, with estimates ranging from $9.17 billion to $10.32 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of analysts that that provide coverage for Westlake Chemical.

Westlake Chemical (NYSE:WLK) last issued its quarterly earnings data on Tuesday, February 19th. The specialty chemicals company reported $1.02 EPS for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.70). Westlake Chemical had a return on equity of 17.83% and a net margin of 11.53%. The company had revenue of $1.96 billion for the quarter, compared to the consensus estimate of $2.10 billion. During the same period in the prior year, the firm posted $1.62 earnings per share. The business’s revenue for the quarter was down 2.7% on a year-over-year basis.

A number of research firms have issued reports on WLK. Barclays reaffirmed a “buy” rating on shares of Westlake Chemical in a report on Wednesday, February 20th. Cowen reiterated a “market perform” rating and issued a $82.00 target price on shares of Westlake Chemical in a research note on Wednesday, February 6th. Zacks Investment Research upgraded shares of Westlake Chemical from a “sell” rating to a “hold” rating in a report on Saturday, January 19th. Nomura lowered shares of Westlake Chemical from a “neutral” rating to a “reduce” rating and set a $72.00 price target on the stock. in a research report on Wednesday, January 30th. Finally, ValuEngine cut shares of Westlake Chemical from a “sell” rating to a “strong sell” rating in a report on Monday, February 4th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and nine have assigned a buy rating to the company’s stock. Westlake Chemical currently has an average rating of “Hold” and an average price target of $101.63.

In other Westlake Chemical news, Director H John Riley, Jr. sold 3,327 shares of the company’s stock in a transaction dated Tuesday, March 19th. The shares were sold at an average price of $69.92, for a total transaction of $232,623.84. Following the sale, the director now directly owns 22,652 shares of the company’s stock, valued at $1,583,827.84. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 72.00% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently bought and sold shares of the company. Norges Bank bought a new position in Westlake Chemical in the 4th quarter worth approximately $32,294,000. Millennium Management LLC raised its position in shares of Westlake Chemical by 102.6% in the fourth quarter. Millennium Management LLC now owns 834,024 shares of the specialty chemicals company’s stock worth $55,187,000 after buying an additional 422,380 shares in the last quarter. Morgan Stanley boosted its stake in Westlake Chemical by 223.3% during the third quarter. Morgan Stanley now owns 544,346 shares of the specialty chemicals company’s stock valued at $45,240,000 after buying an additional 375,952 shares during the period. AQR Capital Management LLC boosted its stake in Westlake Chemical by 20.0% during the third quarter. AQR Capital Management LLC now owns 1,853,189 shares of the specialty chemicals company’s stock valued at $154,018,000 after buying an additional 308,887 shares during the period. Finally, Nuveen Asset Management LLC boosted its stake in Westlake Chemical by 129.9% during the fourth quarter. Nuveen Asset Management LLC now owns 429,443 shares of the specialty chemicals company’s stock valued at $28,416,000 after buying an additional 242,654 shares during the period. Hedge funds and other institutional investors own 28.00% of the company’s stock.

NYSE WLK traded up $1.62 on Thursday, reaching $76.14. The company had a trading volume of 1,923,628 shares, compared to its average volume of 820,571. The company has a current ratio of 2.40, a quick ratio of 1.55 and a debt-to-equity ratio of 0.44. Westlake Chemical has a 52-week low of $59.78 and a 52-week high of $124.29. The firm has a market capitalization of $9.78 billion, a P/E ratio of 9.75, a PEG ratio of 0.89 and a beta of 1.44.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 13th. Investors of record on Wednesday, February 27th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date was Tuesday, February 26th. Westlake Chemical’s dividend payout ratio is currently 12.80%.

About Westlake Chemical

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and building products worldwide. It operates through two segments, Olefins and Vinyls. The Olefins segment offers polyethylene, styrene monomers, and various ethylene co-products, as well as sells propylene, crude butadiene, pyrolysis gasoline, and hydrogen products.

See Also: S&P 500 Index

Get a free copy of the Zacks research report on Westlake Chemical (WLK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Westlake Chemical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Westlake Chemical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Millennium Management LLC Grows Stake in Westlake Chemical Co. (NYSE:WLK)

Millennium Management LLC boosted its position in shares of Westlake Chemical Co. (NYSE:WLK) by 102.6% during the 4th quarter, according to the …

Westlake Chemical logoMillennium Management LLC boosted its position in shares of Westlake Chemical Co. (NYSE:WLK) by 102.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 834,024 shares of the specialty chemicals company’s stock after buying an additional 422,380 shares during the period. Millennium Management LLC owned 0.65% of Westlake Chemical worth $55,187,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in WLK. State Board of Administration of Florida Retirement System increased its holdings in shares of Westlake Chemical by 0.3% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 51,617 shares of the specialty chemicals company’s stock valued at $3,415,000 after purchasing an additional 140 shares during the period. Callahan Advisors LLC boosted its stake in shares of Westlake Chemical by 6.7% in the fourth quarter. Callahan Advisors LLC now owns 4,290 shares of the specialty chemicals company’s stock valued at $284,000 after buying an additional 270 shares in the last quarter. Nissay Asset Management Corp Japan ADV boosted its stake in shares of Westlake Chemical by 12.6% in the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 4,206 shares of the specialty chemicals company’s stock valued at $278,000 after buying an additional 472 shares in the last quarter. Penserra Capital Management LLC purchased a new stake in shares of Westlake Chemical in the fourth quarter valued at approximately $37,000. Finally, Standard Life Aberdeen plc boosted its stake in shares of Westlake Chemical by 37.5% in the third quarter. Standard Life Aberdeen plc now owns 2,891 shares of the specialty chemicals company’s stock valued at $240,000 after buying an additional 789 shares in the last quarter. 28.00% of the stock is currently owned by institutional investors.

In other Westlake Chemical news, Director H John Riley, Jr. sold 3,327 shares of the company’s stock in a transaction dated Tuesday, March 19th. The stock was sold at an average price of $69.92, for a total transaction of $232,623.84. Following the completion of the sale, the director now directly owns 22,652 shares in the company, valued at $1,583,827.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 72.00% of the company’s stock.

Shares of NYSE:WLK traded up $1.92 on Thursday, hitting $73.46. The company had a trading volume of 19,492 shares, compared to its average volume of 772,283. The company has a market capitalization of $9.19 billion, a P/E ratio of 9.41, a P/E/G ratio of 0.83 and a beta of 1.44. Westlake Chemical Co. has a 52-week low of $59.78 and a 52-week high of $124.29. The company has a quick ratio of 1.55, a current ratio of 2.40 and a debt-to-equity ratio of 0.44.

Westlake Chemical (NYSE:WLK) last released its earnings results on Tuesday, February 19th. The specialty chemicals company reported $1.02 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.72 by ($0.70). The business had revenue of $1.96 billion during the quarter, compared to analyst estimates of $2.10 billion. Westlake Chemical had a net margin of 11.53% and a return on equity of 17.83%. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.62 earnings per share. On average, sell-side analysts anticipate that Westlake Chemical Co. will post 7.13 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 13th. Shareholders of record on Wednesday, February 27th were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Tuesday, February 26th. This represents a $1.00 annualized dividend and a yield of 1.36%. Westlake Chemical’s dividend payout ratio is presently 12.80%.

A number of research firms have commented on WLK. Barclays reiterated a “buy” rating on shares of Westlake Chemical in a research report on Wednesday, February 20th. Bank of America upgraded Westlake Chemical from an “underperform” rating to a “buy” rating and set a $85.00 target price on the stock in a research report on Tuesday, January 8th. Zacks Investment Research upgraded Westlake Chemical from a “sell” rating to a “hold” rating in a research report on Saturday, January 19th. Cowen reiterated a “market perform” rating and set a $75.00 target price (down from $100.00) on shares of Westlake Chemical in a research report on Tuesday, December 11th. Finally, Susquehanna Bancshares reiterated a “neutral” rating and set a $75.00 target price (down from $88.00) on shares of Westlake Chemical in a research report on Tuesday, February 26th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and eight have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $102.13.

ILLEGAL ACTIVITY NOTICE: “Millennium Management LLC Grows Stake in Westlake Chemical Co. (NYSE:WLK)” was originally published by Fairfield Current and is the sole property of of Fairfield Current. If you are viewing this report on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this report can be accessed at https://www.fairfieldcurrent.com/news/2019/04/04/westlake-chemical-co-wlk-position-lifted-by-millennium-management-llc.html.

About Westlake Chemical

Westlake Chemical Corporation manufactures and markets basic chemicals, vinyls, polymers, and building products worldwide. It operates through two segments, Olefins and Vinyls. The Olefins segment offers polyethylene, styrene monomers, and various ethylene co-products, as well as sells propylene, crude butadiene, pyrolysis gasoline, and hydrogen products.

Featured Story: What is a front-end load?

Institutional Ownership by Quarter for Westlake Chemical (NYSE:WLK)

Receive News & Ratings for Westlake Chemical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Westlake Chemical and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts